Ischemic stroke is the target of a new partnership between Oxygen Biotherapeutics (NASDAQ:OXBT) and Aurum Biosciences that aims to develop a diagnostic and a treatment for the condition.The agreement will pair the companies’ respective technologies: Aurum’s magnetic resonance imaging (MRI) technology has the potential to map salvageable tissue in the brain after a stroke and [...]

A new, magnet-based technology to destroy blood clots could improve the standard of care for ischemic stroke and deep vein thrombosis, says a St. Louis, Missouri medical device startup.Pulse Therapeutics closed in on $3.1 million late last year for its technology, which is intended to improve the delivery of the thrombolytic drug tPA used in [...]

Behind the highly visible displays of success and influence in the healthcare space at the 2012 Consumer Electronics Show — like UnitedHealth Group‘s two-part, walk-through exhibit space and Qualcomm’s ever-present sponsor signage — there were a few modest young companies showing off their innovative technologies. Here are three that managed to catch my attention:ValencellFitness apps [...]

A startup that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has received a state loan for nearly $1 million.The $943,000 in financing for Cincinnati-area IschemiaCare comes through the Innovation Ohio Loan Fund program, which is aimed at helping companies in the state develop “next-generation” products.IschemiaCare‘s [...]

A company that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has closed $800,000 of an anticipated $1.1 million series B round of investment.Cincinnati-area-based IschemiaCare expects to close on the full $1.1 million by the end of the year. The funding will enable the company to [...]

A promising traumatic brain injury and stroke treatment company that spun out from Cleveland Clinic has shut down, with backers of the startup hoping the technology behind the business can be revived sometime later. CSF Therapeutics was launched with lots of optimism and a $4 million venture capital investment four years ago. But the Clinic and others associated with the company now refer to the business as “on hiatus,” “hibernating” or “dormant.”

Don’t accuse molecular diagnostics startup Ischemia Care of thinking small. The Oxford, Ohio-based company that was founded three years ago is hoping to be the first company to market with a blood test to diagnose the cause of stroke, the fourth-leading cause of death in the United States. And it’s hoping to do that within two years.

The fast track can, over time, take its toll. New research in women finds a high-stress, demanding job with little or no growth potential can raise the risk of heart problems — including heart attack or stroke, or even early death — by 40 percent.

The most promising application of Athersys Inc.’s (NASDAQ:ATHX) stem cell technology lies in treating stroke victims, according to a Morningstar Inc. analyst. “It’s really market potential that leads us to believe that stroke is the most promising indication,” said Lauren Migliore.

A recently introduced Ohio House bill aims to improve the care of stroke patients in the state, in part by publicly designating hospitals that have demonstrated excellence in caring for stroke victims.The proposed law would create the designation of “primary stroke centers” to help the public know which hospitals have been certified as providing high-quality [...]